BC
CCCC icon

BIT Capital’s C4 Therapeutics CCCC Stock Holding History

BIT Capital’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-138,899
Closed -$792K – 117
2024
Q3 		$792K Buy
+138,899
New +$836K 0.07% 78
2024
Q2 		– Sell
-168,090
Closed -$1.37M – 109
2024
Q1 		$1.37M Buy
+168,090
New +$1.3M 0.1% 78
2022
Q2 		– Sell
-3,800
Closed -$92.2K – 119
2022
Q1 		$92.2K Buy
+3,800
New +$92.3K 0.01% 108

Other funds holding CCCC

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIT Capital's CCCC Position: Q4 2024 in Review

BIT Capital sold out of C4 Therapeutics (CCCC) in Q4 2024, closing a stake of 138,899 shares — an estimated $792K sold.

BIT Capital first reported a position in CCCC in Q1 2022 and held it in 3 quarters. The position peaked at $1.37M in Q1 2024. 113 funds tracked by Wall St. Rank hold CCCC as of Q4 2024.

  • BIT Capital reported no remaining C4 Therapeutics position as of Q4 2024 after selling out during the quarter.
  • BIT Capital sold 138,899 C4 Therapeutics shares in Q4 2024, an estimated $792K.
  • BIT Capital first reported a position in C4 Therapeutics in Q1 2022 and held it in 3 quarters.
  • BIT Capital's C4 Therapeutics position peaked at $1.37M in Q1 2024.
  • 113 funds tracked by Wall St. Rank held C4 Therapeutics as of Q4 2024.

Based on BIT Capital's 13F filing for Q4 2024, filed 12 Feb 2025.